Your session is about to expire
← Back to Search
Needle Nerve Contact in Ultrasound Guided Femoral Block
N/A
Waitlist Available
Led By Xavier Sala-Blanch, MD
Research Sponsored by Hospital Clinic of Barcelona
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 months
Awards & highlights
No Placebo-Only Group
Summary
Ultrasound-guided femoral nerve block is a common regional anesthesia technique. The optimal method of needle guidance (in-plane versus out-of-plane) with regards to the block efficacy and avoidance of needle-nerve contact has not been established. In this study the investigators tests the hypothesis that the incidence of needle-nerve contact is higher with the needle insertion in an out-of-plane than with the in-plane approach.
Eligible Conditions
- Peripheral Nerve Injury
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 4 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Number of intraneural needle insertion in ultrasound-guided femoral block: out-of-plane versus in-plane approach
Secondary study objectives
Number of Participants with femoral block success in ultrasound-guided femoral block: out-of-plane versus in-plane approach.
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: out of plane needle placementExperimental Treatment1 Intervention
Group II: in plane needle placementExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
Hospital Clinic of BarcelonaLead Sponsor
431 Previous Clinical Trials
5,411,178 Total Patients Enrolled
Xavier Sala-Blanch, MDPrincipal InvestigatorUniversity Clinic Barcelona
2 Previous Clinical Trials
80 Total Patients Enrolled
Ana Ruiz, MDPrincipal InvestigatorUniversity of Barcelona
Julia Martinez-Ocon, MDStudy ChairUniversity of Barcelona
Admir Hadzic, Prof DrStudy DirectorColumbia University St Luke's Hospital
Gerard Sánchez-Etayo, MDStudy ChairUniversity of Barcelona
Maria J Carretero, MDStudy ChairUniversity of Barcelona